Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats

Tetrathiomolybdate (TM), a drug developed for Wilson's disease, produces an anti-angiogenic and anti-inflammatory effect by reducing systemic copper levels. TM therapy has proved effective in inhibiting the growth of tumors in animal tumor models and in cancer patients. We have hypothesized tha...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Omoto, Atsushi, Kawahito, Yutaka, Prudovsky, Igor, Tubouchi, Yasunori, Kimura, Mizuho, Ishino, Hidetaka, Wada, Makoto, Yoshida, Makie, Kohno, Masataka, Yoshimura, Rikio, Yoshikawa, Toshikazu, Sano, Hajime
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2005
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1297562/
https://ncbi.nlm.nih.gov/pubmed/16277669
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1801
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items